Search research articles
Contact Us
Filters
Showing results (141-150 of 179) with videos related to
Page
of 18
Sort By:
Cancer Immunology, Immunotherapy : CII
|
February 13, 2024
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
Kathryn Kline, Tim Luetkens, Rima Koka, et al.
Human Vaccines & Immunotherapeutics
|
June 6, 2023
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)
Kathryn Kline, Wengen Chen, Michael E Kallen, et al.
Blood
|
September 25, 2010
Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial
Edward A Stadtmauer, Dan T Vogl, Eline Luning Prak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2021
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial
Matthew J Frank, Nasheed M Hossain, Ali Bukhari, et al.
Blood Advances
|
July 26, 2024
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells
Mehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork, et al.
Bone Marrow Transplantation
|
March 16, 2002
Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy
A P Rapoport, B Meisenberg, C Sarkodee-Adoo, et al.
Communications Biology
|
December 17, 2021
Deep dissection of the antiviral immune profile of patients with COVID-19
Djordje Atanackovic, Stephanie V Avila, Forat Lutfi, et al.
Blood Advances
|
July 28, 2025
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL
Kirk E Cahill, James K Godfrey, Chadi Nabhan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 19, 2004
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study
G L Phillips, B Meisenberg, D E Reece, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 15, 2023
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by <sup>18</sup>F-FDG PET/CT Imaging Following CAR-T Therapy
Forat Lutfi, Olga Goloubeva, Amer Kowatli, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 179) with videos related to
Sort By:
Page
of 18
Cancer Immunology, Immunotherapy : CII
|
February 13, 2024
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
Kathryn Kline, Tim Luetkens, Rima Koka, et al.
Human Vaccines & Immunotherapeutics
|
June 6, 2023
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)
Kathryn Kline, Wengen Chen, Michael E Kallen, et al.
Blood
|
September 25, 2010
Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial
Edward A Stadtmauer, Dan T Vogl, Eline Luning Prak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2021
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial
Matthew J Frank, Nasheed M Hossain, Ali Bukhari, et al.
Blood Advances
|
July 26, 2024
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells
Mehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork, et al.
Bone Marrow Transplantation
|
March 16, 2002
Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy
A P Rapoport, B Meisenberg, C Sarkodee-Adoo, et al.
Communications Biology
|
December 17, 2021
Deep dissection of the antiviral immune profile of patients with COVID-19
Djordje Atanackovic, Stephanie V Avila, Forat Lutfi, et al.
Blood Advances
|
July 28, 2025
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL
Kirk E Cahill, James K Godfrey, Chadi Nabhan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 19, 2004
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study
G L Phillips, B Meisenberg, D E Reece, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 15, 2023
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by <sup>18</sup>F-FDG PET/CT Imaging Following CAR-T Therapy
Forat Lutfi, Olga Goloubeva, Amer Kowatli, et al.
Page
of 18